Two new HIV drugs, Emtriva and Reyataz

Two new HIV drugs, Emtriva and Reyataz, will help simplify drug regimens...because they're each given just ONCE a day.

Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir).

Emtriva is well-tolerated. It DOESN'T affect cytochrome P450 enzymes...therefore drug interactions aren't likely.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote